Over timeparticularly as patients transition from the active-weight-loss phase to long-term maintenancethe psychological burden of ongoing injections can become more apparent, Akshay Jain, a clinical instructor at the University of British Columbia, told me
Originally, Semaglutide was designed to be a treatment for people with type 2 diabetes, but during testing it became apparent that it also provides major benefits for weight loss as well
Liver regeneration after acetaminophen hepatotoxicity: mechanisms and therapeutic opportunities
Together, they create a more significant pulse of growth hormone than either could achieve alone
The decision to continue or discontinue should be individualized with your healthcare provider based on treatment response, tolerability, and overall health status
However, that date is not a guarantee, as Novo Nordisk could opt to seek extensions on their patent protection, as they are currently doing in Brazil